Malignant Uveal Neoplasm — Trials

Malignant Uveal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 101–104 of 104 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003802	Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma	completed	Phase 2	—	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Dec 17, 2012	clinicaltrials
NCT00750399	Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma	completed	Phase 1	10	The New York Eye Cancer CenterOTHER	1	Apr 26, 2012